{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:54:32Z","timestamp":1776326072699,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017645","name":"Moorfields Eye Charity","doi-asserted-by":"publisher","award":["R190001"],"award-info":[{"award-number":["R190001"]}],"id":[{"id":"10.13039\/501100017645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41931-3","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:04:32Z","timestamp":1772870672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study"],"prefix":"10.1038","volume":"16","author":[{"given":"Ismail","family":"Moghul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas","family":"Pontikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anitta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Soomro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried K.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Sousa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiu Wai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"41931_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","volume":"401","author":"RH Guymer","year":"2023","unstructured":"Guymer, R. H. & Campbell, T. G. Age-related macular degeneration. Lancet 401, 1459\u20131472 (2023).","journal-title":"Lancet"},{"key":"41931_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein, M. et al. Age-related macular degeneration. Nat. Rev. Dis. Primers 7, 31 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"41931_CR3","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"41931_CR4","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"RD Jager","year":"2008","unstructured":"Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N. Engl. J. Med. 358, 2606\u20132617 (2008).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"41931_CR5","doi-asserted-by":"publisher","first-page":"p1","DOI":"10.1016\/j.ophtha.2019.09.024","volume":"127","author":"J Christina","year":"2020","unstructured":"Christina, J. et al. Age-Related Macular Degeneration Preferred Practice Pattern\u00ae Flaxel. Ophthalmology 127(1), p1\u2013p65 (2020).","journal-title":"Ophthalmology"},{"issue":"5","key":"41931_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide, R. F. et al. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology 127(5), 616\u2013636 (2020).","journal-title":"Ophthalmology"},{"key":"41931_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0161-6420(95)30846-9","volume":"102","author":"P Mitchell","year":"1995","unstructured":"Mitchell, P., Smith, W., Attebo, K. & Wang, J. J. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102, 1450\u20131460 (1995).","journal-title":"Ophthalmology"},{"key":"41931_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1350-9462(98)00025-1","volume":"18","author":"R Klein","year":"1999","unstructured":"Klein, R., Klein, B. E. & Cruickshanks, K. J. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog. Retin. Eye Res. 18, 371\u2013389 (1999).","journal-title":"Prog. Retin. Eye Res."},{"key":"41931_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0161-6420(00)00580-7","volume":"108","author":"W Smith","year":"2001","unstructured":"Smith, W. et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108, 697\u2013704 (2001).","journal-title":"Ophthalmology"},{"key":"41931_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.survophthal.2006.05.001","volume":"51","author":"S Haddad","year":"2006","unstructured":"Haddad, S., Chen, C. A., Santangelo, S. L. & Seddon, J. M. The genetics of age-related macular degeneration: A review of progress to date. Surv. Ophthalmol. 51, 316\u2013363 (2006).","journal-title":"Surv. Ophthalmol."},{"key":"41931_CR11","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1093\/hmg\/ddx228","volume":"26","author":"MM DeAngelis","year":"2017","unstructured":"DeAngelis, M. M. et al. Genetics of age-related macular degeneration (AMD). Hum. Mol. Genet. 26, R45\u2013R50 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"41931_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/eye.2017.245","volume":"32","author":"A Warwick","year":"2018","unstructured":"Warwick, A. & Lotery, A. Genetics and genetic testing for age-related macular degeneration. Eye 32, 849\u2013857 (2018).","journal-title":"Eye"},{"key":"41931_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/archopht.123.3.321","volume":"123","author":"JM Seddon","year":"2005","unstructured":"Seddon, J. M. et al. The US twin study of age-related macular degeneration: Relative roles of genetic and environmental influences. Arch. Ophthalmol. 123, 321\u2013327 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"41931_CR14","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1093\/hmg\/ddx181","volume":"26","author":"RF Mullins","year":"2017","unstructured":"Mullins, R. F., Warwick, A. N., Sohn, E. H. & Lotery, A. J. From compliment to insult: Genetics of the complement system in physiology and disease in the human retina. Hum. Mol. Genet. 26, R51\u2013R57 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"41931_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.preteyeres.2017.09.001","volume":"62","author":"CB Toomey","year":"2018","unstructured":"Toomey, C. B., Johnson, L. V. & Bowes Rickman, C. Complement factor H in AMD: Bridging genetic associations and pathobiology. Prog. Retin. Eye Res. 62, 38\u201357 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"41931_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108605","volume":"210","author":"A May","year":"2021","unstructured":"May, A. et al. Ongoing controversies and recent insights of the ARMS2-HTRA1 locusin age-related macular degeneration. Exp. Eye Res. 210, 108605 (2021).","journal-title":"Exp. Eye Res."},{"key":"41931_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","volume":"109","author":"F Priv\u00e9","year":"2022","unstructured":"Priv\u00e9, F. et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am. J. Hum. Genet. 109, 12\u201323 (2022).","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"41931_CR18","first-page":"2461","volume":"260","author":"A Abbas","year":"2022","unstructured":"Abbas, A. et al. Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 260(8), 2461\u20132473 (2022).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"41931_CR19","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","volume":"28","author":"JN Acosta","year":"2022","unstructured":"Acosta, J. N., Falcone, G. J., Rajpurkar, P. & Topol, E. J. Multimodal biomedical AI. Nat. Med. 28, 1773\u20131784 (2022).","journal-title":"Nat. Med."},{"key":"41931_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00712-8","volume":"5","author":"A Kline","year":"2022","unstructured":"Kline, A. et al. Multimodal machine learning in precision health: A scoping review. NPJ Digit. Med. 5, 171 (2022).","journal-title":"NPJ Digit. Med."},{"key":"41931_CR21","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"41931_CR22","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. http:\/\/arxiv.org\/abs\/1603.02754 (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"41931_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche, L. G. et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 48, 134\u2013143 (2016).","journal-title":"Nat. Genet."},{"key":"41931_CR24","doi-asserted-by":"crossref","unstructured":"Woof W, de Guimar\u00e3es TAC, Al-Khuzaei S, Varela MD et al. Quantification of Optical Coherence Tomography Features in >3500 Patients with Inherited Retinal Disease Reveals Novel Genotype-Phenotype Associations. medRxiv [Preprint]. 2025 Jul 3:2025.07.03.25330767.","DOI":"10.1101\/2025.07.03.25330767"},{"key":"41931_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010295","author":"A W\u0105sowska","year":"2022","unstructured":"W\u0105sowska, A. et al. Polygenic risk score impact on susceptibility to age-related macular degeneration in Polish patients. J. Clin. Med. Res. https:\/\/doi.org\/10.3390\/jcm12010295 (2022).","journal-title":"J. Clin. Med. Res."},{"key":"41931_CR26","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.6.14","volume":"10","author":"A Qassim","year":"2021","unstructured":"Qassim, A. et al. Risk stratification and clinical utility of polygenic risk scores in ophthalmology. Transl. Vis. Sci. Technol. 10, 14 (2021).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"41931_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-00341-z","volume":"3","author":"S-C Huang","year":"2020","unstructured":"Huang, S.-C. et al. Fusion of medical imaging and electronic health records using deep learning: A systematic review and implementation guidelines. NPJ Digit. Med. 3, 136 (2020).","journal-title":"NPJ Digit. Med."},{"key":"41931_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.survophthal.2012.01.006","volume":"57","author":"PA Keane","year":"2012","unstructured":"Keane, P. A. et al. Evaluation of age-related macular degeneration with optical coherence tomography. Surv. Ophthalmol. 57, 389\u2013414 (2012).","journal-title":"Surv. Ophthalmol."},{"key":"41931_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva, A. et al. A guide to deep learning in healthcare. Nat. Med. 25, 24\u201329 (2019).","journal-title":"Nat. Med."},{"key":"41931_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100965","volume":"85","author":"TT Hormel","year":"2021","unstructured":"Hormel, T. T. et al. Artificial intelligence in OCT angiography. Prog. Retin. Eye Res. 85, 100965 (2021).","journal-title":"Prog. Retin. Eye Res."},{"issue":"5","key":"41931_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","volume":"128","author":"G Moraes","year":"2021","unstructured":"Moraes, G. et al. Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning. Ophthalmology 128(5), 693\u2013705 (2021).","journal-title":"Ophthalmology"},{"issue":"1","key":"41931_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/tvst.10.1.27","volume":"10","author":"L Terry","year":"2021","unstructured":"Terry, L., Trikha, S., Bhatia, K. K., Graham, M. S. & Wood, A. Evaluation of automated multiclass fluid segmentation in optical coherence tomography images using the Pegasus fluid segmentation algorithms. Transl. Vis. Sci. Technol. 10(1), 27 (2021).","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"9","key":"41931_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ph13090257","volume":"13","author":"T Shijo","year":"2020","unstructured":"Shijo, T., Sakurada, Y., Yoneyama, S. & Kikushima, W. Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals (Basel) 13(9), 257 (2020).","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41931-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:16:12Z","timestamp":1776323772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41931-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41931"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41931-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"KB has received speaker fees from Novartis, Bayer, Roche; meeting or travel fees from Novartis and Bayer; consulting fees from Novartis, Roche, Bayer and Boehringer-Ingleheim; research support from Apellis, Novartis, and Bayer; employment AAvantgarde Bio. PAK received grants or contracts by a UK Research & Innovation Future Leaders Fellowship (MR\/R019050\/1) and The Rubin Foundation Charitable Trust; consulting fees from Retina Consultants of America, Topcon, Roche and Boehringer-Ingleheim; payment or honoraria from Zeiss, Topcon, Novartis, Boehringer-Ingleheim, Apellis, Roche and AbbVie; support for attending meetings and\/or travel from Bayer, Topcon and Roche; Active patents: Generalizable medical image analysis using segmentation and classification neural networks\n                      \n                      and Pending Patents: Predicting disease progression from tissue images and tissue segmentation maps\n                      \n                      ; participation on a Data Safety Monitoring Board or Advisory Board for Topcon, Bayer, Boehringer-Ingleheim, RetinAI and Novartis; Bitfount (stock options) and Big Picture Medical (stock). SS received grants (paid to her institution) from Bayer and Boehringer Ingelheim; consulting fees for participation on advisory boards from AbbVie, Amgen, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Eyepoint Phamaceuticals, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics, and Sanofi; honoraria for lectures from Bayer, and Roche, for presentations from Bayer, Roche, Astellas, and Abbvie, and for manuscript writing and educational events from Bayer, Roche, and Boehringer Ingleheim; support for attending meetings and\/or travel from Boehringer Ingelheim, Roche, and Bayer; participation in Data Safety Monitoring Boards for Bayer and Novo Nordisk; is a Trustee of the Macular Society and Chair of the Royal College of Ophthalmologists\u2019 Scientific Committee; and has stock options in Eyebiotech. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12489"}}